Patient Gateway

RSS Feed

Frontier Medicines to Present First Clinical Data for FMC-376, an Equipotent KRAS G12C ON+OFF Inhibitor, at ESMO Congress 2026

KRAS G12S Positive Non-Small Cell Lung Cancer Mimicking KRAS G12C Positivity on the AmoyDx PCR Panel: A Case Report

VS-7375 Shows Antitumor Activity in PDAC, Other KRAS G12D–Mutant Tumors

Verastem's KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC

VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors

VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors

Efficacy and safety of immune checkpoint inhibitor plus bevacizumab-based chemotherapy in advanced or recurrent KRAS-mutant non-squamous NSCLC: the SPIRAL-STONE study

Herbert Loong: KRAS G12C in Asia, and Why the Landscape Still Matters

Trethera wins Fast Track for dCK inhibitor TRE-515 in KRAS G12C lung cancer combination

FDA Grants Fast Track Designation to TRE-515 for KRAS G12C NSCLC